Algoneurodystrophy

M13_ALGONEURO

reflex sympathetic dystrophy: Complex regional pain syndrome type 1 (CRPS1) is a form of complex regional pain syndrome (see this term) in which the pain is disproportionate to any known inciting event and is characterized by continuous pain, allodynia, or hyperalgesia as well as edema, coloration (changes in skin blood flow), or abnormal sudomotor activity in the region of pain. Onset of CRPS1 symptoms may occur within a few days to a month after an injury or trauma to the affected limb.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M89.0 Hospital discharge: ICD-9 — 7337 Cause of death: ICD-10 — M89.0 Cause of death: ICD-9 — 7337 2 out of 7 registries used, show all original rules.	1262
4. Check minimum number of events None	1262
5. Include endpoints None	1262
6. Filter based on genotype QC (FinnGen only)	1262

Control definitions (FinnGen only)

Control exclude: M13_OSTEOCHONDRO

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M89
Name in latin: Algoneurodystrophia

NAME	M13_ALGONEURO
CONTROL_EXCLUDE	M13_OSTEOCHONDRO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M890
HD_ICD_9	7337
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M890
COD_ICD_9	7337
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Algoneurodystrophy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8238	5702	2485
Only index persons	7987	5588	2399
Unadjusted period prevalence (%)
Whole population	0.13	0.16	0.07
Only index persons	0.17	0.21	0.09
Median age at first event (years)
Whole population	47.60	47.38	48.14
Only index persons	47.48	47.27	47.97

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1262	967	295
Unadjusted period prevalence (%)	0.28	0.33	0.13
Median age at first event (years)	46.85	46.06	49.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1133: Matched controls
11330

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M89.0

ICD-10 Finland

Algoneurodystrophy

+∞

323.0

1124

N03AX16

ATC

pregabalin; oral

12.2

308.5

752

1580

N03AX12

ATC

gabapentin; oral

13.3

295.5

617

932

G56.4

ICD-10 Finland

Causalgia

199.5

194.8

198

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

11.6

185.8

381

473

N02AX02

ATC

tramadol; systemic, rectal

5.8

163.4

766

3004

N06AX21

ATC

duloxetine; oral

8.2

154.0

396

699

M79.6

ICD-10 Finland

Pain in limb

4.6

124.1

671

2730

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

61.1

115.7

135

R52.2

ICD-10 Finland

Other chronic pain

15.1

102.8

177

137

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

25.6

101.5

144

N06AA09

ATC

amitriptyline; systemic

6.8

98.1

277

518

R4120

NOMESCO Finland

Occupational therapy

8.6

97.4

228

322

N02AA05

ATC

oxycodone; systemic

6.0

89.1

275

571

N03AX09

ATC

lamotrigine; oral

7.9

75.6

184

270

N06AX16

ATC

venlafaxine; oral

4.1

73.1

338

1056

M25.5

ICD-10 Finland

Pain in joint

3.4

73.0

499

2150

X59

ICD-10 Finland

Exposure to unspecified factor

4.0

72.8

359

1188

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.1

71.6

685

3732

X58

ICD-10 Finland

Exposure to other specified factors

4.4

71.2

302

867

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.4

70.2

445

1799

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.1

67.7

586

2938

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

38.2

66.8

TAC00

NOMESCO Finland

Peripheral nerve block

78.8

66.0

R51.80

ICD-10 Finland

Headache

3.9

64.9

318

1031

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

4.0

64.8

305

954

R52.1

ICD-10 Finland

Chronic intractable pain

22.1

61.1

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

4.8

61.1

226

557

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.9

60.8

291

918

N02AJ06

ATC

codeine and paracetamol; systemic

2.8

58.6

572

3003

Z3226

NOMESCO Finland

Physiotherapist

3.5

58.1

323

1147

M54.5

ICD-10 Finland

Low back pain

2.9

57.4

521

2602

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.4

56.5

229

615

M54.4

ICD-10 Finland

Lumbago with sciatica

3.4

55.4

319

1159

A02BC02

ATC

pantoprazole; systemic

2.8

54.6

814

5414

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.1

53.7

156

288

R4110

NOMESCO Finland

Physiotherapy

2.9

51.3

394

1738

N06AA10

ATC

nortriptyline; systemic

10.7

50.0

100

M01AH05

ATC

etoricoxib; oral

2.6

49.8

794

5329

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

11.7

49.5

N06AX11

ATC

mirtazapine; oral

2.7

48.4

474

2407

N02BE01

ATC

paracetamol; systemic, rectal

3.9

48.4

1036

8310

TAD02

NOMESCO Finland

Sympathetic block of ganglion stellatum

108.9

48.2

G54.0

ICD-10 Finland

Brachial plexus disorders

9.1

47.9

104

124

A01

ICPC

Pain general/multiple sites

5.0

47.9

167

380

ND1AA

NOMESCO Finland

Wrist X-ray examination

5.6

47.7

149

299

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

39.5

47.7

ZXA00

NOMESCO Finland

Right side

2.8

47.0

376

1683

H02AB06

ATC

prednisolone; systemic

2.5

46.7

609

3604

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.2

45.9

154

335

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.4

44.8

177

457

W00

ICD-10 Finland

Fall on same level involving ice and snow

3.9

44.4

204

605

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.4

42.9

168

429

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

42.7

350

1574

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

7.3

42.1

105

156

S18

ICPC

Laceration/cut

2.4

42.0

512

2869

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

4.9

40.8

143

325

M03BX02

ATC

tizanidine; oral

2.4

40.2

822

5906

WX002

NOMESCO Finland

Sedation and analgesia

2.9

39.9

284

1161

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.1

39.5

170

473

ZXE10

NOMESCO Finland

More than one and less than three hours

2.4

39.3

475

2625

N03AE01

ATC

clonazepam; systemic

5.0

39.2

135

301

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.6

39.0

375

1833

R52.9

ICD-10 Finland

Pain, unspecified

4.0

38.9

170

479

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.2

38.6

160

429

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

38.2

379

1880

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

4.1

38.1

163

450

ZXA05

NOMESCO Finland

Left side

2.6

38.0

333

1538

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

37.8

370

1816

N05AH04

ATC

quetiapine; oral

2.8

37.5

282

1186

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.0

37.5

148

L28

ICPC

Limited function/disability (L)

3.3

37.2

208

713

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.5

37.0

190

612

S52.5

ICD-10 Finland

Fracture of lower end of radius

3.8

36.6

170

504

Z3231

NOMESCO Finland

Registered nurse

2.5

36.5

377

1902

TAC99

NOMESCO Finland

Other blockade for chronic pain

25.4

36.5

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

62.2

36.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

35.8

487

2810

M03BX01

ATC

baclofen; systemic

11.8

34.9

L11

ICPC

Wrist symptom/complaint

3.8

34.7

161

476

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

4.6

34.1

126

301

L12

ICPC

Hand/finger symptom/complaint

2.9

34.0

237

945

J01FF01

ATC

clindamycin; systemic

2.4

33.9

376

1950

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

33.9

475

2760

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

4.6

33.7

125

300

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.9

33.6

231

911

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

5.1

33.2

110

234

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.9

33.0

175

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.1

32.7

138

374

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

12.9

32.6

M01AB05

ATC

diclofenac; systemic, rectal

2.2

32.4

821

6147

AA1AD

NOMESCO Finland

CT of head and brain

2.6

32.4

276

1240

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.2

32.1

185

646

S06.0

ICD-10 Finland

Concussion

3.4

31.9

168

548

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.1

31.9

192

691

M79.7

ICD-10 Finland

Fibromyalgia

5.6

31.9

187

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

31.7

224

895

M54.2

ICD-10 Finland

Cervicalgia

3.8

31.5

143

413

A02BC05

ATC

esomeprazole; systemic

2.1

31.3

516

3189

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.7

31.3

252

1093

R42

ICD-10 Finland

Dizziness and giddiness

2.6

31.3

271

1223

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

10.3

31.2

NDA30

NOMESCO Finland

Exploration of joint of wrist or hand, arthroscopic

18.5

31.2

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

31.1

372

1989

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

5.4

30.9

194

Z2446

NOMESCO Finland

Social worker

4.2

30.8

124

322

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.1

30.5

128

345

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.4

30.4

159

516

S93.4

ICD-10 Finland

Sprain and strain of ankle

3.0

30.2

193

722

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

30.2

251

1107

ACC51

NOMESCO Finland

Release of median nerve

3.6

30.1

146

446

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

4.3

29.9

116

290

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

29.7

170

588

J01DB01

ATC

cefalexin; oral

2.5

29.7

979

8095

A06AD11

ATC

lactulose; oral

3.2

29.3

170

595

R06.0

ICD-10 Finland

Dyspnoea

2.4

29.2

294

1434

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

7.3

28.9

103

N05BA01

ATC

diazepam; systemic, rectal

2.9

28.7

196

764

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

28.7

300

1488

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

28.5

316

1615

L16

ICPC

Ankle symptom/complaint

3.1

28.5

169

598

R03AC02

ATC

salbutamol; inhalant

2.0

28.4

662

4647

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

10.6

28.2

M79.1

ICD-10 Finland

Myalgia

2.8

28.2

206

838

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.4

28.1

150

493

TQW40

NOMESCO Finland

Remowal of suture of skin

3.7

28.1

129

376

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

27.8

263

1239

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

27.7

354

1930

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.8

27.5

146

ZXD05

NOMESCO Finland

Urgent procedure

2.1

27.4

408

2377

A02BC01

ATC

omeprazole; systemic

2.2

27.4

336

1794

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

27.4

146

479

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

27.3

362

2004

M01AH01

ATC

celecoxib; oral (coxibs)

2.5

27.3

249

1149

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.7

27.1

208

869

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

26.8

425

2535

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.5

26.7

238

1084

P01AB01

ATC

metronidazole; oral, rectal

2.0

26.6

531

3476

L17

ICPC

Foot/toe symptom/complaint

2.2

26.5

327

1747

AEA20

NOMESCO Finland

Removal of impulse generator of stimulation device in the nervous system

53.0

26.3

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.1

26.0

157

562

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

5.1

26.0

178

M01AH02

ATC

rofecoxib; oral

2.9

25.9

179

699

S80.0

ICD-10 Finland

Contusion of knee

3.6

25.9

123

368

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

5.7

25.8

141

A02BC03

ATC

lansoprazole; oral

2.1

25.7

353

1975

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

7.4

25.6

N07BC02

ATC

methadone; systemic

45.4

25.6

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

29.2

25.5

WX204

NOMESCO Finland

Axillary plexus blockaced

6.0

25.4

127

M54.1

ICD-10 Finland

Radiculopathy

5.1

25.4

174

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

3.0

25.3

160

589

S63.3

ICD-10 Finland

Traumatic rupture of ligament of wrist and carpus

8.9

25.2

G44.2

ICD-10 Finland

Tension-type headache

2.6

25.2

213

937

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.7

25.0

187

767

A03FA01

ATC

metoclopramide; systemic, rectal

2.3

25.0

279

1416

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

24.9

462

2914

W22

ICD-10 Finland

Striking against or struck by other object(s)

3.9

24.8

108

300

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

24.5

501

3273

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.4

24.4

243

1166

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

7.7

24.4

L09

ICPC

Arm symptom/complaint

4.6

24.4

205

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

4.3

24.2

235

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

4.2

24.2

240

Z50.1

ICD-10 Finland

Other physical therapy

3.9

24.0

103

282

G43.9

ICD-10 Finland

Migraine, unspecified

3.4

24.0

122

385

W19

ICD-10 Finland

Unspecified fall

3.3

23.9

130

431

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

23.7

617

4379

M02AA07

ATC

piroxicam; topical

2.0

23.7

424

2622

L03

ICPC

Low back symptom/complaint

2.1

23.5

321

1777

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

55.2

23.1

T93.2

ICD-10 Finland

Sequelae of other fractures of lower limb

15.1

23.1

J01AA02

ATC

doxycycline; systemic

2.1

23.0

906

7452

M48.0

ICD-10 Finland

Spinal stenosis

3.2

23.0

132

455

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

22.8

275

1441

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

23.5

22.7

N02AC04

ATC

dextropropoxyphene; oral

6.1

22.6

109

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

22.6

177

743

G56.2

ICD-10 Finland

Lesion of ulnar nerve

4.7

22.6

178

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

4.0

22.6

246

M01AX17

ATC

nimesulide; oral

2.2

22.5

288

1545

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

3.4

22.5

113

353

J01DA01

ATC

[U] cefalexin; systemic

1.9

22.3

749

5763

J01MA02

ATC

ciprofloxacin; systemic

1.9

22.3

436

2774

WX110

NOMESCO Finland

Local anesthesy

1.9

22.2

827

6597

Z2445

NOMESCO Finland

Psychologist

4.3

22.2

205

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

22.1

266

W10

ICD-10 Finland

Fall on and from stairs and steps

4.2

21.7

219

M77.1

ICD-10 Finland

Lateral epicondylitis

2.9

21.6

138

511

NH1AD

NOMESCO Finland

Ankle and foot CT

7.3

21.5

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

44.3

21.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.3

21.4

203

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

6.7

21.3

SPAT1153

SPAT

Removal of sutures

2.0

21.3

350

2076

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

7.0

21.3

N03AF02

ATC

oxcarbazepine; oral

5.2

21.3

135

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

8.0

21.2

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.7

21.2

276

R52.0

ICD-10 Finland

Acute pain

5.2

21.1

136

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

8.3

21.1

SPAT1229

SPAT

Assessment of need for aid

3.4

21.1

108

342

M01AE02

ATC

naproxen; oral, rectal

1.8

21.1

693

5240

N05CF01

ATC

zopiclone; oral

2.0

21.1

362

2184

M89.9

ICD-10 Finland

Disorder of bone, unspecified

+∞

20.9

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

20.9

377

2313

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

20.9

320

1847

J01FA06

ATC

roxithromycin; oral

1.8

20.8

493

3335

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.7

20.5

268

A28

ICPC

Limited function/disability NOS

2.9

20.2

130

483

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

10.6

20.2

N03AX11

ATC

topiramate; oral

5.2

20.0

127

L08

ICPC

Shoulder symptom/complaint

2.2

20.0

233

1192

R55

ICD-10 Finland

Syncope and collapse

2.9

20.0

129

481

T92.2

ICD-10 Finland

Sequelae of fracture at wrist and hand level

12.9

20.0

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

19.9

222

1114

N05CD07

ATC

temazepam; oral

2.8

19.9

141

555

TAD10

NOMESCO Finland

General sympathetic block

+∞

19.8

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

19.8

292

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

12.4

19.6

T92.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of upper limb

14.1

19.6

SPAT1216

SPAT

Assessment of functional ability

2.6

19.5

159

681

N05BA04

ATC

oxazepam; oral

2.0

19.5

310

1807

R60.0

ICD-10 Finland

Localized oedema

2.8

19.3

129

492

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.5

19.1

278

N06AB06

ATC

sertraline; oral

2.5

19.1

169

756

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.1

19.0

248

1331

N06AB04

ATC

citalopram; systemic

2.0

18.9

281

1591

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

18.9

158

686

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

18.7

661

5018

S63.5

ICD-10 Finland

Sprain and strain of wrist

4.2

18.7

179

S60.0

ICD-10 Finland

Contusion of finger(s) without damage to nail

4.7

18.6

142

XF400

NOMESCO Finland

ECG with 12 standard connections

2.4

18.4

170

775

N03AF01

ATC

carbamazepine; oral, rectal

3.7

18.2

229

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

18.0

302

ZXE00

NOMESCO Finland

One hour or less

1.8

18.0

471

3240

B01AB05

ATC

enoxaparin; parenteral

1.9

18.0

319

1924

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

18.0

191

WX290

NOMESCO Finland

Other blockade of nerve

1.7

18.0

565

4117

XA402

NOMESCO Finland

ENMG

4.8

18.0

134

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

4.1

17.9

182

ZYC01

NOMESCO Finland

Remote contact by phone

3.6

17.8

234

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

17.8

110

396

M84.0

ICD-10 Finland

Malunion of fracture

+∞

17.8

M50.3

ICD-10 Finland

Other cervical disc degeneration

5.5

17.7

101

SPAT1254

SPAT

Administration of medicine

2.4

17.7

168

778

UJF32

NOMESCO Finland

Coloscopy

2.0

17.7

273

1563

WX124

NOMESCO Finland

Intravenous local anesthesy of leg

96.6

17.6

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

182.7

17.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

17.5

231

1241

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.1

17.4

101

350

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

6.2

17.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

17.4

156

700

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

6.0

17.4

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.0

17.4

104

368

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

5.2

17.3

108

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

17.3

357

2268

N28

ICPC

Limited function/disability (N)

11.3

17.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.1

17.3

328

C07AB07

ATC

bisoprolol; oral

1.8

17.2

431

2914

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

17.2

214

1122

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

3.4

17.1

263

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.1

17.1

170

R33

ICD-10 Finland

Retention of urine

3.9

17.1

190

Z71.8

ICD-10 Finland

Other specified counselling

1.9

17.1

301

1808

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.9

17.0

119

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.6

17.0

131

540

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

9.2

17.0

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.0

17.0

181

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

19.6

16.9

M01AC06

ATC

meloxicam; systemic, rectal

1.8

16.9

418

2814

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

16.9

839

6963

L01

ICPC

Neck symptom/complaint

2.2

16.8

191

959

C03CA01

ATC

furosemide; systemic

2.1

16.8

217

1153

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.9

16.8

188

RF210

NOMESCO Finland

4.9

16.7

117

M25.2

ICD-10 Finland

Flail joint

8.1

16.6

H01

ICPC

Ear pain/earache

2.4

16.6

156

717

R06AE07

ATC

cetirizine; oral

1.7

16.6

538

3921

TAB00

NOMESCO Finland

Lumbar puncture

3.5

16.5

238

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.5

16.5

137

R1250

NOMESCO Finland

Evaluation of functional capability

5.5

16.5

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.5

16.5

233

A02BA02

ATC

ranitidine; systemic

2.1

16.4

214

1140

R50.9

ICD-10 Finland

Fever, unspecified

2.3

16.3

169

815

N29

ICPC

Neurological sympt/complt other

6.5

16.2

L15

ICPC

Knee symptom/complaint

2.0

16.1

250

1428

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

15.9

112

438

Z3229

NOMESCO Finland

Other healthcare associate professional

2.8

15.9

105

396

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

3.6

15.9

213

K07.60

ICD-10 Finland

Snapping jaw

3.1

15.9

313

ZY010

NOMESCO Finland

Hospital outpatient

3.2

15.9

279

SPAT1240

SPAT

Therapeutic discussion

2.2

15.7

167

815

Z00.0

ICD-10 Finland

General medical examination

2.0

15.6

218

1192

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

3.4

15.6

232

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

5.6

15.5

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

4.8

15.4

110

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

15.2

101

383

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.7

15.1

105

409

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

3.5

15.1

211

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

5.4

15.1

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.9

14.9

342

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

14.9

258

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.9

14.9

167

ZXD20

NOMESCO Finland

Day surgery

2.2

14.8

170

857

C01CA24

ATC

epinephrine; parenteral

2.7

14.8

105

411

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

14.8

138

631

P76

ICPC

Depressive disorder

2.7

14.7

105

415

M35.7

ICD-10 Finland

Hypermobility syndrome

6.0

14.6

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.6

14.6

111

455

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

14.6

350

M54.3

ICD-10 Finland

Sciatica

3.0

14.6

313

A03

ICPC

Fever

2.0

14.5

206

1131

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.2

14.5

252

M24.2

ICD-10 Finland

Disorder of ligament

5.9

14.4

H02AB04

ATC

methylprednisolone; systemic

2.1

14.3

178

926

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.1

14.3

NDG20

NOMESCO Finland

Fusion of wrist, partial

19.4

14.3

UKC02

NOMESCO Finland

Cystoscopy

2.3

14.3

146

698

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

4.3

14.2

129

WX702

NOMESCO Finland

Supraglottic ventilation device

3.0

14.2

284

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

3.8

14.2

169

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

14.2

619

4819

N03A

ATC

ANTIEPILEPTICS

43.1

14.1

JAH01

NOMESCO Finland

Laparoscopy

3.0

14.1

279

K02.1

ICD-10 Finland

Caries of dentine

1.6

14.1

668

5309

T78.4

ICD-10 Finland

Allergy, unspecified

3.0

14.0

287

R51

ICD-10 Finland

Headache

3.0

14.0

296

XQ800

NOMESCO Finland

Prick test

2.4

14.0

122

539

SPAT1284

SPAT

Extensive health certificate

4.1

14.0

136

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.4

13.9

119

520

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.6

13.9

107

441

R11

ICD-10 Finland

Nausea and vomiting

2.7

13.9

385

M81.9

ICD-10 Finland

Osteoporosis, unspecified

6.4

13.9

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

3.5

13.9

188

J01FA10

ATC

azithromycin; systemic

1.6

13.8

706

5706

G56.3

ICD-10 Finland

Lesion of radial nerve

11.6

13.8

SGC00

NOMESCO Finland

Local medication of root channels of tooth

2.2

13.8

150

737

R03BA05

ATC

fluticasone; inhalant

1.9

13.8

224

1295

M01AC01

ATC

piroxicam; systemic, rectal

2.2

13.8

145

701

M65.3

ICD-10 Finland

Trigger finger

3.3

13.7

222

R51.81

ICD-10 Finland

Facial pain NOS

4.9

13.7

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

13.7

182

975

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

13.7

550

4173

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.3

13.6

120

NCK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of elbow or forearm, other location

+∞

13.6

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

3.9

13.6

150

AEA27

NOMESCO Finland

Replacement of spinal stimulation electrode

34.5

13.5

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.5

13.5

107

R03BA02

ATC

budesonide; inhalant

1.9

13.5

211

1201

J01MA12

ATC

levofloxacin; systemic

2.0

13.5

182

979

M01AX01

ATC

nabumetone; oral

3.4

13.5

198

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

13.4

134

633

Z02.7

ICD-10 Finland

Issue of medical certificate

2.8

13.4

326

TAB20

NOMESCO Finland

Epidural puncture

11.6

13.3

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.6

13.3

173

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

13.2

150

751

N05CF02

ATC

zolpidem; oral

1.9

13.2

227

1338

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

3.9

13.2

144

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

8.0

13.1

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

13.1

122

557

R53

ICD-10 Finland

Malaise and fatigue

1.9

13.1

223

1308

R13

ICD-10 Finland

Dysphagia

3.1

13.1

242

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

3.3

13.0

209

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.9

13.0

305

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.8

12.9

278

1761

RF420

NOMESCO Finland

7.1

12.9

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

4.0

12.9

132

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.6

12.8

S01

ICPC

Pain/tenderness of skin

3.5

12.8

179

Z04.3

ICD-10 Finland

Examination and observation following other accident

5.3

12.8

N06AA12

ATC

doxepin; systemic

3.1

12.8

244

M05BA04

ATC

alendronic acid; oral

3.1

12.7

246

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

4.4

12.7

105

N01

ICPC

Headache

2.1

12.6

148

749

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

12.6

457

3350

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.1

12.6

156

807

XG410

NOMESCO Finland

Flow-volume spirometry

3.6

12.6

160

M89

ICD-10 Finland

Other disorders of bone

+∞

12.5

7337A

ICD-9 Finland

Other disorders of bone and cartilage, Algoneurodystrophy

+∞

12.5

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

5.2

12.5

NDE40

NOMESCO Finland

Plastic repair of ligament or capsule of wrist with transplant

20.3

12.5

N06AX03

ATC

mianserin; oral

3.2

12.4

217

R60.9

ICD-10 Finland

Oedema, unspecified

3.4

12.3

179

T93.3

ICD-10 Finland

Sequelae of dislocation, sprain and strain of lower limb

8.6

12.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

12.3

259

1627

C07AA05

ATC

propranolol; systemic

1.8

12.3

236

1440

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

5.1

12.2

K08.80

ICD-10 Finland

Toothache NOS

2.3

12.2

116

534

R03DC03

ATC

montelukast; oral

1.9

12.2

201

1161

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

3.0

12.2

254

R02

ICPC

Shortness of breath/dyspnoea

2.2

12.2

134

659

WZA90

NOMESCO Finland

Other doctors statement

1.7

12.1

268

1706

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

5.0

12.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

12.1

588

4622

WX308

NOMESCO Finland

Sacral anesthesy

18.3

12.1

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

12.0

302

1998

T92.4

ICD-10 Finland

Sequelae of injury of nerve of upper limb

21.5

12.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

12.0

261

1657

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

13.5

12.0

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

11.9

149

774

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.0

11.9

247

D07AD01

ATC

clobetasol; topical

1.9

11.8

188

1074

M77.0

ICD-10 Finland

Medial epicondylitis

4.0

11.8

118

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

3.8

11.8

133

R01AD08

ATC

fluticasone; nasal

1.7

11.7

337

2312

NC2AA

NOMESCO Finland

Forearm X-ray examination

6.1

11.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.2

11.7

198

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

16.6

11.7

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

3.3

11.7

187

R96

ICPC

Asthma

2.4

11.7

431

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

11.6

149

783

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

11.6

211

1264

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

11.6

199

1166

M54.8

ICD-10 Finland

Other dorsalgia

3.2

11.6

194

P29

ICPC

Psychological sympt/compl other

2.6

11.6

366

WX203

NOMESCO Finland

Infraclavicular plexus blockade

4.2

11.5

106

SPAT1263

SPAT

Sampling

1.6

11.5

456

3400

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

13.8

11.5

L99

ICPC

Musculoskeletal disease other

4.7

11.5

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

11.5

361

2539

R05FB02

ATC

cough suppressants and expectorants

1.6

11.5

395

2841

WX402

NOMESCO Finland

General anaesthesia

1.9

11.4

193

1125

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.2

11.4

196

SPAT1301

SPAT

No procedures

1.6

11.4

322

2198

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.5

11.4

382

R5599

NOMESCO Finland

Other rehabilitation service

4.0

11.4

112

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.7

11.3

319

R01AD09

ATC

mometasone; nasal

1.5

11.3

531

4114

A02BC04

ATC

rabeprazole; oral

2.3

11.3

105

479

N99

ICPC

Neurological disease other

7.7

11.2

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

5.0

11.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

11.2

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.7

11.2

N02AA03

ATC

hydromorphone; systemic, rectal

25.3

11.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.8

11.1

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

5.9

11.1

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.7

11.1

SPAT1211

SPAT

Application of soft bandage

2.3

11.1

104

478

M01AH03

ATC

valdecoxib; oral

2.6

11.0

327

L86

ICPC

Back syndrome with radiating pain

2.7

11.0

294

J46

ICD-10 Finland

Status asthmaticus

4.0

11.0

111

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.5

10.9

348

NBT60

NOMESCO Finland

Forcible manipulation of humeroscapular joint

4.8

10.9

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

10.9

130

664

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

4.2

10.9

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

3.1

10.9

197

1220

FHL

Arthroscopy

3.4

10.9

153

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

5.0

10.9

A11

ICPC

Chest pain NOS

2.6

10.8

318

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

10.8

125

631

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

10.8

104

483

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.9

10.8

237

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

10.7

194

1155

P03

ICPC

Feeling depressed

2.1

10.7

132

682

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

10.7

189

1119

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.8

10.7

263

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

10.7

172

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

10.7

115

562

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

2.1

10.7

122

613

H02AB07

ATC

prednisone; oral

1.9

10.6

155

855

T93.8

ICD-10 Finland

Sequelae of other specified injuries of lower limb

60.6

10.6

S43.0

ICD-10 Finland

Dislocation of shoulder joint

3.5

10.6

140

R25.1

ICD-10 Finland

Tremor, unspecified

4.2

10.6

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

3.3

10.6

162

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

3.0

10.6

212

EBA00

NOMESCO Finland

Extraction of tooth

1.6

10.6

356

2535

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

10.5

125

637

S22.3

ICD-10 Finland

Fracture of rib

2.7

10.5

284

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.3

10.5

441

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.6

10.5

131

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

10.5

100

463

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.8

10.5

237

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

10.5

361

2584

AXX90

NOMESCO Finland

Intravascular test of medication against pain

+∞

10.4

ABD33

NOMESCO Finland

Revision of electrical stimulation device of spine or nerve roots

+∞

10.4

F61.0

ICD-10 Finland

Mixed personality disorders

5.0

10.4

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

5.0

10.4

M13.9

ICD-10 Finland

Arthritis, unspecified

2.4

10.4

363

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.8

10.4

117

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.5

10.3

326

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.6

10.3

133

M70.6

ICD-10 Finland

Trochanteric bursitis

2.0

10.3

141

759

G57.8

ICD-10 Finland

Other mononeuropathies of lower limb

10.7

10.3

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

10.7

10.3

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

10.3

299

2045

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

7.5

10.2

M01AB55

ATC

diclofenac, combinations; oral

2.6

10.2

310

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

10.2

125

646

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

10.2

162

921

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.3

10.2

L29

ICPC

Musculoskeletal sympt/complt other

2.4

10.2

381

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.9

10.2

104

L02

ICPC

Back symptom/complaint

2.1

10.2

116

582

N03AG01

ATC

valproic acid; systemic, rectal

2.5

10.1

354

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

10.1

139

750

K10.3

ICD-10 Finland

Alveolitis of jaws

2.6

10.0

281

T92.1

ICD-10 Finland

Sequelae of fracture of arm

10.1

10.0

R03AC03

ATC

terbutaline; inhalant

1.9

10.0

161

920

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

10.0

125

648

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

10.0

207

1285

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.4

10.0

142

R10.0

ICD-10 Finland

Acute abdomen

3.4

10.0

142

M94.2

ICD-10 Finland

Chondromalacia

40.4

10.0

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

9.9

251

R05

ICPC

Cough

1.7

9.9

248

1627

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

9.9

143

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

3.2

9.9

165

S83.2

ICD-10 Finland

Tear of meniscus, current

2.3

9.9

404

P01

ICPC

Feeling anxious/nervous/tense

1.9

9.9

144

796

R03BA01

ATC

beclometasone; inhalant

1.9

9.9

158

902

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

9.8

335

7263A

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]

20.2

9.8

ND1DG

NOMESCO Finland

Wrist and hand very extensive MRI examination with high intensity magnet

20.2

9.8

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

690

4039

2.56

58.09

6.4

5.4

mmol/l

1.2

0.14

643

3655

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

730

4500

2.48

53.31

7.1

6.1

mmol/l

1.2

0.14

646

3792

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

777

5019

2.43

49.76

5.3

5.7

umol/l

8.8

10.6

9.25

746

4748

(3024561) Albumin [Mass/volume] in Serum or Plasma

642

3884

2.33

46.85

4.4

4.5

g/l

36.7

36.4

0.62

605

3622

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1032

7736

2.83

45.95

7.9

6.8

u/l

75.1

75.6

0.18

999

7277

(3013826) Glucose [Moles/volume] in Serum or Plasma

821

5573

2.35

44.85

5.6

4.3

mmol/l

6.5

0.01

786

5151

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

489

2698

2.33

43.53

2.6

2.0

u/l

228.8

195.1

0.20

461

2546

(3013707) Erythrocyte sedimentation rate by Westergren method

1018

7706

2.66

42.06

4.9

3.8

mm/h

11.0

10.6

0.48

974

7178

(3037522) Nuclear Ab [Titer] in Serum

326

1526

2.53

41.66

1.5

1.3

titre

414.2

530.5

0.55

309

(42870588) Differential panel, method unspecified - Blood

551

3279

2.21

40.01

5.8

5.5

—

(3013115) Eosinophils [#/volume] in Blood

775

5319

2.18

38.58

6.4

5.7

e9/l

0.2

1.37

702

4739

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

514

3025

2.18

37.86

3.3

2.4

u/l

51.1

55.7

3.08

488

2797

(3013650) Neutrophils [#/volume] in Blood by Automated count

833

5947

2.18

36.59

8.3

8.5

e9/l

4.1

4.0

0.97

740

5242

(3001604) Monocytes [#/volume] in Blood

746

5112

2.12

36.40

6.3

5.4

e9/l

0.6

0.5

1.51

668

4496

(3006315) Basophils [#/volume] in Blood

747

5135

2.11

35.97

6.3

5.5

e9/l

0.0

0.57

668

4508

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

432

2417

2.20

35.73

1.9

1.7

mg/l

1.0

0.18

322

1803

(3018418) pH of Serum or Plasma

462

2669

2.15

35.09

4.0

3.5

7.4

0.79

501

(3033658) Prothrombin time (PT) actual/Normal

427

2410

2.17

34.28

4.5

3.3

97.8

95.9

0.92

408

2340

(3019198) Lymphocytes [#/volume] in Blood

756

5286

2.07

33.94

6.2

5.5

e9/l

2.2

2.0

1.32

696

4732

(3023368) Bacteria identified in Blood by Culture

394

2190

2.16

32.60

4.5

3.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

532

3345

2.02

31.32

3.7

2.9

ng/l

38.7

46.0

0.17

316

1934

(3006504) Eosinophils/100 leukocytes in Blood

695

4801

2.00

31.22

6.2

5.5

2.8

0.02

658

4484

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

371

2045

2.15

31.14

1.4

1.3

iu/ml

39.0

28.3

0.33

659

(3031040) Bacteria [#/volume] in Urine by Automated count

886

6675

2.10

31.13

5.5

3.8

e6/l

327.3

1537.0

1.17

(3022096) Basophils/100 leukocytes in Blood

675

4625

1.99

30.94

6.3

5.5

0.7

0.23

634

4324

(3019069) Monocytes/100 leukocytes in Blood

696

4829

1.98

30.66

6.5

5.7

8.1

8.2

0.23

661

4550

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

362

1987

2.15

30.64

1.4

1.2

u/ml

3.9

9.1

2.31

130

832

(3002030) Lymphocytes/100 leukocytes in Blood

713

4996

1.98

30.44

6.3

5.5

30.4

29.3

1.90

675

4691

(3032080) INR in Blood by Coagulation assay

532

3380

1.99

30.09

6.5

inr

1.1

0.39

147

1069

(3018010) Neutrophils/100 leukocytes in Blood

704

4945

1.96

29.46

6.0

5.3

55.5

56.4

1.16

669

4658

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

560

3651

1.96

29.12

2.1

1.8

pmol/l

95.0

97.7

0.66

300

1878

(3002582) Erythrocytes [#/volume] in Urine

448

2705

2.02

29.06

3.9

2.8

e6/l

18.6

89.8

1.92

357

2025

(3019309) Folate [Moles/volume] in Red Blood Cells

278

1440

2.19

26.83

1.8

1.7

nmol/l

1158.2

1200.4

0.29

226

1105

(3018095) Leukocytes [#/volume] in Urine

513

3321

1.92

26.59

4.6

3.2

e6/l

27.6

85.8

3.17

382

2215

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

255

1293

2.22

25.86

1.9

1.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

194

880

2.42

25.49

2.6

2.3

u/l

34.6

41.2

0.45

164

747

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

101

326

3.28

25.28

1.5

1.6

g/l

0.2

0.29

305

(3042936) Bacteria identified in Isolate by Culture

247

1254

2.21

24.89

2.2

1.9

—

(3000850) Epithelial cells [#/volume] in Urine

324

1840

2.02

24.23

3.0

2.3

e6/l

8.1

7.4

0.26

287

1607

(3018677) aPTT in Platelet poor plasma by Coagulation assay

254

1321

2.16

24.01

2.4

1.9

29.8

29.5

0.44

246

1276

(3037467) Urinalysis macro (dipstick) panel - Urine

898

7087

1.93

23.92

5.2

3.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

199

946

2.31

23.40

2.4

2.0

nmol/l

346.4

373.0

1.11

183

869

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

377

2285

1.93

23.20

2.7

2.0

mg/l

3.0

2.9

0.48

323

1971

(3030467) Casts [#/volume] in Urine by Automated count

399

2464

1.91

23.20

3.7

2.7

e6/l

0.3

0.4

1.01

307

1804

(36304419) Bacteria [Presence] in Urine

398

2456

1.91

23.19

3.7

2.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

222

1120

2.19

22.56

2.1

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

473

3106

1.84

22.51

2.8

2.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

606

4293

1.79

22.35

2.9

2.2

nmol/l

73.3

75.7

1.23

551

3924

(3026008) Bacteria identified in Urine by Culture

432

2771

1.85

22.09

3.7

2.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

482

3198

1.82

22.08

2.8

3.2

mmol/l

2.4

0.16

424

2852

(3026782) Osmolality of Urine

298

1692

2.00

22.05

3.2

2.4

mosm/kgh2o

552.2

538.8

0.42

260

1441

(3023103) Potassium [Moles/volume] in Serum or Plasma

1201

10742

3.44

21.84

19.5

12.0

mmol/l

3.9

0.79

1187

10436

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

344

2058

1.92

21.81

2.3

2.6

ng/l

889.1

816.1

0.12

282

1693

(3019550) Sodium [Moles/volume] in Serum or Plasma

1197

10708

3.29

21.31

19.6

11.9

mmol/l

139.6

139.7

0.62

1186

10425

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

659

4836

1.76

21.08

4.4

3.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1193

10668

3.16

20.94

19.3

11.1

mg/l

18.1

20.9

2.52

1028

8199

(3026493) Urate [Moles/volume] in Serum or Plasma

388

2459

1.83

20.30

2.2

2.3

umol/l

816.4

5305.4

4.80

344

2156

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

183

890

2.24

20.23

1.8

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

114

448

2.70

20.05

1.4

1.2

u/ml

0.2

1.0

1.11

(3024980) IgG subclass 4 [Mass/volume] in Serum

156

3.92

19.91

1.4

1.7

g/l

0.7

0.01

120

(3007164) IgA [Mass/volume] in Serum or Plasma

359

2233

1.85

19.89

1.6

1.4

g/l

2.3

0.08

220

1401

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

180

882

2.21

19.50

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

350

2180

1.84

19.20

4.3

3.5

kg/l

1.2

1.0

0.49

292

(40768797) Stomach Pathology biopsy report

250

1406

1.97

18.70

1.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

278

1641

1.89

17.92

4.1

3.2

ng/l

53.5

356.6

3.96

165

1093

(3003458) Phosphate [Moles/volume] in Serum or Plasma

204

1090

2.04

17.55

5.1

5.3

mmol/l

1.1

1.0

1.21

194

1012

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

397

2625

1.75

17.52

1.4

1.3

u/ml

0.9

1.5

1.32

725

(40758558) Short blood count panel - Blood

389

2558

1.75

17.50

5.7

6.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

248

1430

1.91

17.10

3.5

3.0

mmol/l

0.8

0.83

233

1347

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

252

1466

1.90

16.89

3.2

2.3

e6/l

0.9

1.0

0.35

153

797

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1009

8621

1.85

16.80

4.9

4.1

pmol/l

14.4

14.5

0.75

946

7986

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

203

1109

1.99

16.35

3.0

2.3

22.3

24.0

0.91

177

945

(3005719) IgG [Mass/volume] in Serum or Plasma

154

759

2.17

16.34

2.9

2.7

g/l

10.3

10.5

0.21

139

697

(3003396) Base excess in Arterial blood by calculation

169

871

2.09

15.96

7.4

8.8

mmol/l

0.8

1.1

0.49

139

696

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

491

3517

1.65

15.68

3.4

3.0

u/l

32.1

30.8

0.14

478

3348

(3021960) Folate [Moles/volume] in Serum or Plasma

313

1988

1.76

15.63

1.6

1.4

nmol/l

20.2

21.1

0.50

268

1724

(4062490)

104

4.14

15.51

1.4

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

100

4.20

15.44

1.4

1.3

g/l

6.0

6.9

0.74

(3024139) IgG subclass 3 [Mass/volume] in Serum

100

4.20

15.44

1.4

1.3

g/l

0.3

0.37

(3028192) IgG subclass 2 [Mass/volume] in Serum

100

4.20

15.44

1.4

1.3

g/l

2.8

2.7

0.20

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

141

3.65

15.42

1.2

1.4

nmol/l

0.6

0.23

135

(3022948) Iron [Moles/volume] in Serum or Plasma

231

1343

1.88

15.40

2.9

2.2

umol/l

13.1

14.1

1.36

216

1239

(3022217) INR in Platelet poor plasma by Coagulation assay

172

905

2.04

15.34

12.3

17.4

inr

1.2

0.04

142

(3011397) Hemoglobin [Presence] in Urine by Test strip

350

2313

1.71

15.10

3.9

3.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

214

1225

1.90

14.93

3.0

2.2

g/l

2.4

0.15

199

1131

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

353

2345

1.70

14.91

2.7

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

131

3.69

14.75

1.2

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

230

1357

1.85

14.58

3.5

2.5

e6/l

3.5

0.01

130

695

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

135

662

2.16

14.47

3.9

3.7

ng/l

92.3

79.0

0.49

127

598

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

261

1609

1.78

14.30

2.4

2.7

mmol/l

2.4

0.03

218

1421

(3020630) Protein [Mass/volume] in Serum or Plasma

126

604

2.21

14.28

2.1

2.8

g/l

67.2

67.5

0.20

115

562

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

300

1926

1.73

14.26

1.6

pmol/l

81323398.4

38892701.0

0.32

257

1643

(3035350) Ketones [Presence] in Urine by Test strip

651

5073

1.59

14.23

4.3

3.2

estimate

0.0

0.50

113

943

(3000991) Gas panel - Venous blood

131

645

2.15

13.88

9.1

8.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

128

3.61

13.72

1.2

1.4

nmol/l

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

193

1101

1.89

13.54

2.2

2.5

umol/l

4.9

7.1

2.57

166

945

(3000570) Elastase.pancreatic [Mass/mass] in Stool

282

2.69

13.27

1.5

ug/g

300.7

301.1

0.00

156

(3048689) Calprotectin [Mass/mass] in Stool

235

1437

1.78

13.14

2.3

2.4

ug/g

124.7

105.3

0.28

180

1140

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

156

837

1.99

13.10

2.5

4.3

u/l

221.5

249.9

1.29

146

797

(1761868) Lipid panel - Serum or Plasma

302

4338

0.60

13.09

2.7

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

120

585

2.16

13.03

1.9

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

648

5110

1.55

12.97

5.5

4.4

estimate

0.0

0.50

119

965

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

425

2.34

12.68

1.6

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

120

593

2.13

12.59

1.9

1.6

g/l

1.3

0.05

113

552

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

239

2.77

12.43

1.3

1.6

e6/l

18.9

7.4

0.32

182

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

239

2.77

12.43

1.3

1.6

e6/l

582.7

1413.0

0.56

190

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

132

3.42

12.40

1.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

254

2.69

12.10

2.6

2.9

—

(3009261) Glucose [Presence] in Urine by Test strip

649

5170

1.53

12.06

4.4

3.2

estimate

0.0

0.80

113

930

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

243

2.72

12.05

1.2

1.3

mmol/l

3.6

3.7

0.24

229

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

4.13

11.89

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

4.13

11.89

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

4.13

11.89

1.3

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

188

1108

1.82

11.81

6.1

5.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

4.08

11.70

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

4.08

11.70

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

4.08

11.70

1.3

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

103

494

2.18

11.65

1.5

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

115

588

2.05

11.02

3.7

2.9

kpa

4.6

4.7

0.05

107

567

(3021447) Carbon dioxide [Partial pressure] in Venous blood

131

702

1.97

11.01

4.1

3.5

kpa

5.8

5.9

0.16

123

681

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

292

2.48

10.92

1.4

1.2

u/ml

12.4

2.4

0.55

(36660697) Celiac disease serology panel - Serum

160

919

1.85

10.89

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

130

699

1.96

10.81

3.9

3.5

mmol/l

1.5

2.0

0.61

108

561

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

139

3.17

10.79

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

4.10

10.71

1.8

2.3

e9/l

1.9

1.1

2.29

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

372

2.29

10.61

3.5

3.8

mmol/l

23.9

24.1

0.18

339

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1099

9991

1.77

10.54

6.1

4.8

mu/l

1.7

2.1

1.24

1042

9352

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

297

2.44

10.53

1.5

1.2

u/ml

2.8

10.6

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

152

3.03

10.50

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

152

3.03

10.50

1.3

—

(3021589) Normoblasts [#/volume] in Blood

580

4600

1.48

10.47

9.5

8.1

e9/l

0.0

0.12

478

3802

(3028707) Methadone [Presence] in Urine by Screen method

228

2.62

10.23

4.0

1.9

—

(40761535) Cells panel - Urine sediment

132

729

1.91

10.14

3.8

3.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

406

2.20

10.13

10.2

12.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

196

2.72

9.96

1.3

1.9

g/l

0.0

0.00

185

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

197

2.71

9.87

1.3

1.9

g/l

0.0

0.00

186

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

2.49

9.82

1.3

2.0

g/l

9.3

10.3

1.74

226

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

352

2.26

9.80

1.8

1.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

121

3.21

9.79

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

210

2.64

9.74

1.3

1.9

g/l

0.0

0.50

199

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

502

2.05

9.70

1.6

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

3.04

9.64

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

3.59

9.53

1.0

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

108

3.30

9.49

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

367

2697

1.51

9.42

4.9

3.5

estimate

0.0

1.34

112

951

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

214

2.59

9.39

1.3

1.8

g/l

39.9

38.3

1.28

194

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

251

2.46

9.33

1.4

1.2

u/ml

34.4

43.9

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

3.69

9.30

1.0

1.1

u/l

1.2

1.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

141

820

1.81

9.19

2.4

2.7

1.8

0.02

123

740

(3001122) Ferritin [Mass/volume] in Serum or Plasma

612

4988

1.44

9.15

3.5

2.7

ug/l

85.4

96.5

1.20

570

4677

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

2.36

9.10

1.3

1.9

g/l

3.6

3.8

0.83

211

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

2.36

9.10

1.3

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

2.36

9.10

1.3

1.9

g/l

7.1

7.4

1.11

224

(3011288) Drugs identified in Urine by Screen method

338

2.23

9.03

3.7

2.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

2.37

8.75

1.2

1.9

g/l

2.9

3.0

0.43

215

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

152

2.82

8.71

1.2

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

446

2.05

8.65

1.7

2.1

u/l

38.1

39.0

0.18

406

(3009343) pH of Capillary blood

488

2.00

8.65

3.2

3.1

7.4

—

(3044889) 12 lead EKG panel

819

7085

1.44

8.60

3.8

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

386

2.12

8.56

1.9

1.7

—

(40761511) CBC panel - Blood by Automated count

1197

11302

2.15

8.54

17.0

10.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

857

7483

1.45

8.51

3.7

2.9

u/l

49.4

41.5

1.58

819

7088

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1090

10012

1.65

8.49

15.1

9.9

ml/min/173m2

89.1

86.8

3.43

941

8158

(3044290) Cell count panel - Cerebral spinal fluid

213

2.50

8.48

1.2

1.6

—

(3036489) Thrombin time

388

2.11

8.45

2.3

1.8

20.1

20.9

1.39

335

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

238

2.42

8.44

1.3

2.2

g/l

0.0

0.8

3.37

216

(3018405) Lactate [Moles/volume] in Arterial blood

277

2.30

8.36

4.4

4.3

mmol/l

1.3

0.07

269

(4010399)

124

714

1.82

8.35

1.4

—

(3019060) Gas panel - Arterial blood

502

1.97

8.32

4.1

7.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

496

1.97

8.27

3.2

3.1

kpa

5.3

5.1

1.20

465

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

470

1.99

8.15

3.3

3.1

mmol/l

1.8

1.6

0.23

345

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

332

2457

1.48

8.03

1.7

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.68

8.03

1.3

1.4

u/l

5.6

6.8

0.46

(3020891) Body temperature

310

2.19

7.91

6.2

4.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

210

1414

1.58

7.88

1.9

1.8

1.6

1.4

2.35

187

1276

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1199

11367

2.10

7.81

12.1

9.1

u/l

26.5

26.0

0.61

1169

11027

(3045414) Leukocytes [Presence] in Urine

457

1.97

7.76

1.9

1.7

—

(3022145) Colonoscopy Study observation

173

1119

1.63

7.65

1.3

—

(3019225) pH of Specimen

143

880

1.70

7.65

4.4

3.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.01

7.63

1.0

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

432

1.99

7.60

2.4

2.3

—

(4027681)

3.43

7.55

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

110

630

1.82

7.54

2.0

2.2

ug/l

12.7

6.3

0.71

573

(3037121) Protein [Mass/volume] in Urine

292

2.18

7.40

2.6

3.4

g/l

0.3

0.08

113

(21494755) Public health laboratory ask at order entry panel

1369

0.51

7.38

1.2

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

372

2853

1.43

7.36

3.7

3.0

mmol/l

8.1

7.7

0.85

323

2429

(3023410) Appearance of Cerebral spinal fluid

110

2.96

7.31

1.1

1.8

—

(3022621) pH of Urine by Test strip

110

640

1.79

7.17

3.2

2.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

130

795

1.71

7.12

1.5

1.3

u/ml

107.4

238.5

2.77

118

737

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

5.70

7.07

1.1

1.0

—

(3023520) Reticulocytes [#/volume] in Blood

102

583

1.82

7.05

2.9

2.8

e9/l

78.8

73.1

0.74

432

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

490

3968

1.38

7.00

4.5

3.3

—

(3013512) EKG study

338

2568

1.43

6.99

3.8

3.1

—

(3014051) Protein [Presence] in Urine by Test strip

215

2.33

6.93

2.0

1.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

6.05

6.91

2.0

1.8

ug/l

62.2

50.8

0.29

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.67

6.76

1.0

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

231

2.26

6.71

1.7

1.4

u/l

29.4

24.6

0.47

189

(40768804) Tissue Pathology biopsy report

525

4331

1.36

6.56

2.2

2.0

—

(3022313) Gas panel - Capillary blood

355

2.00

6.56

3.4

3.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1268

0.53

6.50

1.4

1.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

401

1.93

6.39

3.4

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

217

2.26

6.36

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

388

1.94

6.33

10.9

9.8

mmol/l

24.1

24.3

0.34

371

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.69

6.21

1.9

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

226

2.22

6.19

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

562

1.77

6.15

2.5

2.6

ng/l

76.8

137.1

3.11

506

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

3.00

6.13

1.2

2.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

436

1.87

6.13

3.3

2.5

e6/l

0.1

0.2

0.76

414

(3000494) Fungus identified in Specimen by Culture

174

1187

1.54

6.11

1.5

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

323

2.00

6.07

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

100

2.84

6.02

1.1

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

257

2.11

5.93

1.2

titre

64.4

116.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

3.56

5.89

1.6

1.2

u/l

217.4

457.5

0.61

(40768443) Skin Pathology biopsy report

384

1.90

5.87

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1027

9497

1.44

5.82

6.0

4.9

mmol/mol

39.5

38.8

1.50

968

8931

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.82

5.82

1.4

1.1

g/l

0.3

0.23

(3014765) Yersinia sp identified in Stool by Organism specific culture

307

2.00

5.82

1.3

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

126

2.58

5.73

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

126

2.58

5.73

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

310

1.98

5.67

2.8

2.1

163.8

166.8

0.10

298

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

121

2.60

5.65

1.2

1.3

pmol/l

286.0

358.5

0.65

(3017143) Hepatitis C virus Ab [Presence] in Serum

190

1342

1.49

5.65

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

2.56

5.65

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

304

1.99

5.62

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1091

10223

1.50

5.61

4.7

4.0

mmol/l

6.0

5.8

2.96

1026

9497

(3009214) Lutropin [Units/volume] in Serum or Plasma

340

1.93

5.59

1.5

1.3

u/l

9.6

10.8

0.28

278

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.96

5.59

1.6

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

312

1.97

5.57

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

128

2.54

5.56

1.3

1.4

—

(3024928) Oxygen saturation in Venous blood

178

2.29

5.53

2.5

3.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

129

2.52

5.48

1.4

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

3.17

5.48

2.0

2.2

e6/l

997.9

713.6

0.90

(3016879) Cocaine [Presence] in Urine

475

1.78

5.46

3.4

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.98

5.45

1.1

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

598

1.69

5.44

2.5

2.1

u/l

4995.7

4270.5

0.08

252

(3020191) Ethanol [Moles/volume] in Serum or Plasma

3.05

5.39

2.3

1.5

promille

1.2

0.03

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

118

758

1.61

5.37

3.2

3.4

pmol/l

4.5

0.19

104

668

(3021879) Hepatitis B virus core Ab [Presence] in Serum

128

841

1.58

5.30

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.88

5.27

3.3

4.3

umol/l

90.8

204.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.65

5.26

1.6

2.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.37

5.17

1.9

2.1

9.4

11.2

0.44

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.97

5.16

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

883

0.50

5.14

1.2

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

204

2.15

5.12

1.8

1.7

e6/l

14534.9

13504.5

0.06

147

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.03

5.11

1.0

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

323

1.90

5.06

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

219

2.09

5.03

3.0

2.6

—

(3030313) Adrenal Ab [Titer] in Serum

10.06

5.03

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.84

4.99

1.1

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

129

2.44

4.99

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

255

2.00

4.94

2.2

1.6

nmol/l

42.5

40.5

0.23

249

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.69

4.93

1.2

—

76.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

221

2.07

4.92

1.8

1.6

—

(4198724)

3.51

4.90

1.9

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.80

4.89

1.1

1.3

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.32

4.83

1.2

1.1

108.1

97.6

0.74

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.32

4.83

1.2

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

3.30

4.75

1.1

1.5

nmol/l

137.8

150.6

0.51

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

191

2.13

4.71

1.1

1.2

u/ml

3.8

5.3

0.43

(3025159) Blasts/100 leukocytes in Blood

111

726

1.58

4.70

3.8

4.2

0.2

1.2

0.69

157

(3034770) Mitochondria Ab [Titer] in Serum

267

1.95

4.69

1.2

—

1063.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

146

2.29

4.66

1.5

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

2.78

4.63

1.5

1.4

e6/l

111528.1

194105.4

0.21

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

220

2.04

4.60

1.6

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

312

1.87

4.60

4.0

8.5

2.0

1.6

1.35

288

(3027008) Opiates [Presence] in Urine

516

1.67

4.58

3.3

1.7

—

(4306422)

180

2.15

4.57

1.2

—

(3027944) Amphetamines [Presence] in Urine

509

1.68

4.56

3.4

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

168

2.18

4.50

2.1

2.7

kpa

8.2

8.3

0.19

156

(3028300) Cannabinoids [Presence] in Urine

519

1.66

4.49

3.4

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.44

4.47

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

2.95

4.45

1.6

1.7

20.8

38.0

1.60

(3008898) HLA-B27 [Presence]

490

1.68

4.42

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

118

2.40

4.42

3.0

3.2

0.7

1.2

0.41

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

203

2.05

4.41

1.4

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

346

1.80

4.41

1.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

514

1.66

4.40

3.4

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

212

2.01

4.30

2.1

1.9

nmol/l

1.1

0.8

1.28

176

(3017181) Myelocytes/100 leukocytes in Blood

119

809

1.52

4.26

3.9

4.1

0.6

0.9

0.47

208

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

449

1.69

4.24

2.6

1.7

—

(3037756) Immunofixation for Serum or Plasma

140

2.24

4.20

1.2

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

278

1.87

4.19

2.0

2.1

ug/l

3.1

2.1

0.17

255

(3021440) Promyelocytes/100 leukocytes in Blood

114

772

1.52

4.16

3.9

4.2

0.0

0.2

4.92

190

(3023419) Bacteria identified in Sputum by Culture

103

2.46

4.15

2.8

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

316

1.81

4.13

1.9

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

3.78

4.09

1.2

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.88

4.07

1.0

—

(3005570) Glucose [Moles/volume] in Urine

2.48

4.06

2.2

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

2.10

4.04

1.3

1.5

—

(3004616) Nuclear Ab [Presence] in Serum

130

2.26

4.01

1.6

1.3

—

(3000330) Specific gravity of Urine by Test strip

418

1.69

3.99

2.8

—

(3012516) Albumin [Mass/volume] in Urine

315

2558

1.31

3.99

3.4

3.2

mg/l

848.5

336.8

0.67

209

1570

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.47

3.98

1.2

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

305

1.80

3.98

4.2

8.8

0.9

0.64

282

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

177

2.06

3.97

1.3

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

3.28

3.91

1.4

1.1

107.6

111.9

0.18

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.66

3.91

2.4

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

4.19

3.89

1.3

1.1

g/l

37.3

36.9

—

(3022689) Creatine [Moles/volume] in Urine

4.19

3.89

1.1

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

345

1.74

3.88

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

222

1722

1.35

3.86

2.2

2.1

—

(4146454)

2.62

3.81

2.7

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

2.50

3.81

4.1

7.0

mg/l

9.9

11.5

1.25

(3017732) Neutrophils [#/volume] in Blood

110

755

1.50

3.79

2.2

2.7

e9/l

3.7

3.9

0.45

629

(3020682) Albumin/Creatinine [Ratio] in Urine

326

2683

1.29

3.71

4.2

3.9

mg/mmol

10.6

8.1

0.34

208

1642

(3002179) Metamyelocytes/100 leukocytes in Blood

108

743

1.50

3.68

3.8

4.0

0.6

0.05

147

(3021901) Oxygen saturation in Capillary blood

129

2.20

3.65

2.2

2.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

564

1.56

3.65

2.8

2.1

nmol/l

11.4

12.2

0.42

510

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

292

1.78

3.62

1.7

2.1

g/l

1.4

0.08

255

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

205

1.93

3.61

1.2

—

(3018572) Chloride [Moles/volume] in Blood

184

1.98

3.61

3.4

12.6

mmol/l

104.6

105.1

0.20

166

(3039000) Anion gap in Blood

184

1.98

3.61

3.4

12.6

mmol/l

11.6

11.1

0.48

166

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

192

1.96

3.56

1.1

1.2

u/ml

1.9

4.1

—

(3007461) Platelets [#/volume] in Blood

1232

12039

1.98

3.51

26.8

16.6

e9/l

270.4

260.3

6.56

1213

11774

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

156

1162

1.39

3.49

4.5

4.0

29.1

32.1

2.91

120

829

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.63

3.48

1.1

1.2

—

(3024731) MCV [Entitic volume]

1232

12047

1.95

3.37

26.7

16.6

90.5

0.04

1225

11908

(3035941) MCH [Entitic mass]

1232

12049

1.95

3.33

26.7

16.5

30.1

30.2

0.92

1225

11909

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.73

3.33

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.73

3.33

1.0

—

(3026361) Erythrocytes [#/volume] in Blood

1232

12050

1.94

3.32

26.8

16.6

e12/l

4.5

0.29

1211

11763

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

652

1.49

3.30

1.1

1.0

—

(3010813) Leukocytes [#/volume] in Blood

1232

12053

1.93

3.27

26.8

16.7

e9/l

7.0

6.7

3.24

1211

11760

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

780

0.59

3.26

1.3

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.04

3.25

1.0

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

380

1.64

3.23

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1232

12057

1.92

3.20

27.0

16.7

g/l

134.8

135.5

1.23

1225

11920

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

110

2.20

3.20

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

5.36

3.19

1.0

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

2.49

3.13

3.8

3.0

65.1

52.2

1.51

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

187

1.90

3.12

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

290

2399

1.27

3.12

1.8

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

3.10

3.09

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

3.25

3.06

1.6

1.1

nmol/l

169.9

101.6

0.37

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.45

3.05

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

109

782

1.43

3.03

1.6

1.3

iu/l

30.8

29.0

0.23

670

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

125

921

1.40

3.00

1.3

1.2

iu/ml

96.8

136.8

0.71

378

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

196

1551

1.31

2.96

2.1

1.9

—

(4034850)

334

1.64

2.96

13.9

8.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

193

1.84

2.86

1.3

3.8

mg/l

23.2

31.6

1.29

156

(3034860) Kappa light chains.free [Mass/volume] in Serum

193

1.84

2.86

1.3

3.8

mg/l

30.8

69.3

0.62

156

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

114

836

1.40

2.82

3.1

4.3

ug/l

10.2

22.2

0.61

659

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

103

2.16

2.81

2.4

2.0

mg/l

9.1

22.8

1.92

(3044242) Glucose [Moles/volume] in Arterial blood

3.07

2.81

2.6

3.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

8.36

2.75

1.0

1.2

ng/l

142.2

105.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

122

911

1.38

2.72

3.7

2.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

204

1.79

2.71

1.5

1.4

—

(3011648) Oxygen content in Venous blood

2.35

2.65

2.7

3.7

12.3

11.0

0.62

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.14

2.65

1.0

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

191

1.80

2.64

1.6

1.4

u/ml

105.2

110.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

191

1.80

2.64

1.1

1.0

u/ml

1.2

1.9

—

(3021788) Differential panel - Synovial fluid

155

1.89

2.62

1.8

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

229

1.73

2.62

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

2.27

2.61

1.4

1.2

—

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

133

1015

1.35

2.59

2.2

1.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.91

2.58

1.0

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

340

1.58

2.55

1.8

1.6

iu/ml

0.0

0.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

348

1.58

2.55

1.7

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

296

2509

1.23

2.54

4.6

4.2

—

(3025941) Bacteria identified in Stool by Culture

597

1.44

2.50

1.6

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

158

1.86

2.49

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.40

2.46

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.57

2.44

1.5

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.25

2.44

1.2

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

212

1.72

2.41

1.1

1.2

u/ml

266.8

237.3

0.32

130

(1616796) Gas panel - Central venous blood

168

1.80

2.38

3.7

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.08

2.38

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

2.16

2.35

1.4

1.2

—

52.6

—

(3045424) Erythrocytes [Presence] in Urine

177

1.77

2.31

1.5

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

842

0.67

2.29

1.8

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

321

2774

1.21

2.26

1.7

mmol/l

1.6

1.4

1.66

281

2368

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.90

2.25

1.0

1.1

—

(3002256) Pathology report gross observation

163

1311

1.28

2.20

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

297

1.57

2.19

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

188

1.72

2.18

3.3

3.5

mg/l

16.9

25.0

0.76

117

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.01

2.15

3.2

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.22

2.11

1.0

1.2

—

(3004451) EKG impression Narrative

2.72

2.10

1.1

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.15

2.09

1.0

1.1

nmol/l

0.1

0.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

222

1.64

2.07

1.4

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.92

2.07

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.92

2.07

1.0

1.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.92

2.07

1.0

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

2.04

2.06

1.6

1.9

nmol/l

17.8

21.3

0.74

(3047007) Chlamydophila sp Ab [Presence] in Serum

192

1.68

2.04

1.1

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

453

0.59

2.04

1.4

1.5

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

4.01

2.04

1.0

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

4.01

2.04

1.3

2.4

mmol/l

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

177

1.71

2.03

2.0

2.2

g/l

131.5

130.5

0.09

134

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.06

2.01

1.3

1.4

—

(3024263) Appearance of Synovial fluid

2.51

2.01

1.6

2.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.74

1.93

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

173

1.69

1.90

1.1

iu/ml

1.3

2872.4

—

(4268621)

128

1.81

1.90

2.1

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

158

1.72

1.90

2.3

2.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

1.87

0.0

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.66

1.86

1.0

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.66

1.86

3.0

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

1.91

1.86

1.2

1.3

u/ml

0.1

0.9

—

(3020491) Glucose [Moles/volume] in Blood

2.04

1.85

1.9

1.6

mmol/l

6.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.54

1.84

1.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

2.07

1.81

1.1

—

(3042631) Mycobacterium sp identified in Specimen

1.93

1.80

2.5

2.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

3.05

1.80

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.77

1.79

1.4

1.2

pmol/l

336.1

331.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.77

1.79

1.0

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

734

1.32

1.77

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

102

1.88

1.76

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

1.58

1.75

3.2

2.9

u/ml

0.4

0.10

110

(3016650) Hepatitis A virus Ab [Presence] in Serum

170

1.66

1.74

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.23

1.74

2.8

2.7

49.9

44.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.51

1.74

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.68

1.72

1.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

3.86

1.71

1.4

1.8

mmol/l

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

229

1967

1.20

1.71

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

148

1.70

1.71

1.4

4.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.39

1.68

1.1

1.0

iu/ml

208.5

190.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

134

1.73

1.67

1.6

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

3.17

1.66

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.11

1.66

1.5

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.81

1.65

5.6

3.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.04

1.65

1.2

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

197

1.59

1.63

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

375

0.61

1.60

1.5

1.6

—

(3017569) Oxygen content in Arterial blood

2.51

1.60

2.9

4.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.01

1.58

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

101

801

1.28

1.57

2.1

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

216

1.54

1.55

1.4

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

298

1.46

1.55

2.6

3.4

u/ml

631.2

4247.0

0.55

254

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.98

1.54

2.4

2.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.28

1.53

1.1

1.6

pmol/l

12.1

13.9

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.34

1.52

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

183

0.49

1.51

1.6

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.87

1.50

1.2

1.1

—

(4015189)

2.87

1.50

3.2

3.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

415

0.64

1.48

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

415

0.64

1.48

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

415

0.64

1.48

1.3

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

147

1.64

1.48

1.5

2.7

u/ml

—

685.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

414

0.64

1.47

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.85

1.46

4.5

4.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

117

1.72

1.45

1.0

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

954

9187

1.16

1.45

21.8

13.6

13.7

13.5

2.48

947

8995

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

148

1.63

1.45

2.2

1.8

—

1744.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

125

1.69

1.44

1.3

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.04

1.43

1.3

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

2.74

1.43

1.2

3.6

54.8

53.1

—

(44813793)

1.83

1.41

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

272

1.45

1.38

1.2

1.1

u/ml

0.8

2.2

0.97

116

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.95

1.38

1.3

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

501

0.69

1.37

1.3

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

322

2898

1.15

1.35

4.0

2.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.92

1.33

2.7

2.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

667

1.28

1.33

1.3

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

282

0.60

1.31

1.2

1.5

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

2.10

1.30

1.8

2.1

umol/l

51.6

49.4

—

(3051611) Lipemic interference index of Serum or Plasma

1.85

1.30

4.1

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

169

1.55

1.29

1.1

1.0

—

(3028433) Virus identified in Specimen by Culture

2.36

1.29

1.1

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.94

1.28

1.4

1.5

u/l

6.2

5.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.05

1.27

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

178

1.53

1.27

2.0

2.3

umol/l

3.9

5.0

0.87

128

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.23

1.24

1.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.23

1.24

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.23

1.24

1.4

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

155

1.56

1.23

3.7

2.1

15.8

16.6

0.35

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

147

1.58

1.23

1.7

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.01

1.23

1.3

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.05

1.22

1.4

2.7

u/ml

450.5

857.6

—

(3051593) INR in Capillary blood by Coagulation assay

2.31

1.18

7.3

7.8

—

(40768446) Kidney Pathology biopsy report

2.11

1.18

1.4

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

429

1.32

1.18

1.6

—

(3044941) Cell count panel - Synovial fluid

141

1.57

1.17

1.4

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

345

0.66

1.17

1.3

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

333

0.65

1.17

1.8

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

240

1.43

1.17

1.3

1.4

nmol/l

0.2

0.4

1.06

191

(3010726) Horse dander IgE Ab [Units/volume] in Serum

232

1.43

1.16

1.1

u/ml

0.4

3.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.06

1.15

1.1

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

126

1.60

1.15

1.6

2.3

u/ml

5.3

36.7

0.49

118

(4035726)

102

846

1.22

1.14

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

167

1.51

1.13

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

151

1.53

1.12

1.3

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.97

1.11

1.9

2.0

—

22.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.74

1.09

1.1

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.74

1.09

1.1

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.74

1.09

1.1

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.19

1.08

1.0

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.87

1.07

1.4

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1.67

1.04

1.3

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

334

0.68

1.02

1.3

1.4

—

(4024509)

1.69

1.01

1.6

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.69

1.01

1.1

1.0

—

(3051651) Icteric interference index of Serum or Plasma

1.89

1.01

4.9

2.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.89

1.01

1.1

miu/ml

1393.8

1804.4

—

(3005033) Fetal Nuchal fold Thickness US

333

0.68

1.01

1.3

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.01

1.00

2.4

2.2

mg/l

9.5

10.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

795

1.21

0.99

2.9

2.3

ml/min/173m2

71.3

72.5

0.12

315

(3003888) Timothy IgE Ab [Units/volume] in Serum

240

1.39

0.99

1.1

u/ml

5.6

0.00

123

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.18

0.98

1.2

2.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

284

1.35

0.97

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

241

1.38

0.97

2.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1.62

0.94

1.1

1.2

u/l

45.8

55.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

200

1.41

0.94

1.8

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.15

0.91

4.3

2.0

umol/l

8.2

17.7

—

(3003338) MCHC [Mass/volume]

975

9498

1.12

0.91

23.4

14.3

g/l

331.6

332.4

2.03

969

9429

(21494814) CD8 cells/100 lymphocytes in Specimen

2.07

0.89

1.3

2.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

127

1.50

0.88

1.4

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

155

0.58

0.88

1.0

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

103

1.56

0.87

1.1

—

(3024471) HLA-A [Type]

2.00

0.87

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.82

0.86

1.0

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.82

0.86

1.0

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.82

0.86

1.0

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.82

0.86

1.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.63

0.84

3.4

3.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

179

1.40

0.84

1.4

1.3

mmol/l

7.7

7.2

0.26

128

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

154

1.44

0.83

1.0

1.1

—

(44790049)

121

1.49

0.83

1.4

1.5

—

(44806118)

121

1.49

0.83

1.4

1.5

—

(44790047)

121

1.49

0.83

1.4

1.5

—

(44790048)

121

1.49

0.83

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

146

1.45

0.82

1.4

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.74

0.82

2.1

ug/l

20.9

188.3

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

163

1.42

0.82

2.4

2.0

—

4.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

232

1.34

0.81

1.1

u/ml

0.3

1.6

1.36

(3010421) pH of Blood

215

1.36

0.81

4.7

2.5

7.4

0.72

173

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.82

0.79

1.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.82

0.79

1.0

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.82

0.79

1.0

1.8

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.67

0.78

1.5

2.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.77

0.76

1.0

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

124

1.46

0.75

1.2

1.3

—

(40765096) Chromosome analysis panel by Banding

2.09

0.74

1.6

1.0

—

(3042733) HLA Ab [Presence] in Serum

2.09

0.74

5.0

5.8

—

(3034426) Prothrombin time (PT)

1.85

0.73

1.1

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.00

0.72

1.0

1.1

—

(3033799) Differential panel - Peritoneal fluid

2.00

0.72

1.8

1.6

—

(3045788) Cell count panel - Pleural fluid

1.80

0.72

1.1

1.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

310

1.27

0.70

1.7

2.0

iu/l

4.5

4.7

0.05

117

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.86

0.68

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

118

0.59

0.68

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.52

0.66

1.4

1.5

g/l

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.79

0.66

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.79

0.66

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.66

1.4

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.79

0.66

1.2

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.79

0.66

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.79

0.66

1.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

459

1.21

0.65

1.3

miu/ml

128.1

237.2

2.56

236

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

535

0.82

0.64

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1090

10736

1.11

0.64

5.0

4.4

mmol/l

2.9

0.87

1016

10076

(3037556) Urate [Mass/volume] in Serum or Plasma

1.73

0.64

1.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.64

0.62

2.4

1.6

—

(3024932) HLA-DR beta [Type]

1.67

0.61

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

0.60

0.0

1.3

—

(3003694) ABO and Rh group [Type] in Blood

334

3149

1.08

0.60

1.5

—

(3017704) Immunofixation for Urine

1.72

0.57

1.3

1.5

—

(40768795) Lymph node Pathology biopsy report

0.58

0.56

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

129

1423

0.90

0.56

1.6

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.58

0.54

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

183

1691

1.10

0.53

3.9

4.0

ug/l

1.6

2.0

0.87

168

1539

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

134

1.35

0.53

2.4

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

743

1.14

0.52

3.8

2.9

mmol/l

1.2

0.17

623

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.43

0.52

1.0

1.1

—

19.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

556

1.16

0.51

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

197

1.27

0.51

3.6

4.0

56.4

57.2

0.14

197

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

215

1.26

0.51

1.4

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1074

10598

1.09

0.50

4.5

4.0

mmol/l

4.8

0.15

1016

10003

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.56

0.49

1.1

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

107

0.65

0.48

2.3

2.9

u/ml

14.9

57.9

—

107

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.52

0.48

1.1

1.5

—

(3012565) Volume of 24 hour Urine

1.49

0.47

1.7

2.5

1835.7

1918.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

148

1364

1.10

0.47

3.7

21.8

20.9

0.25

563

(3006462) Nitrate [Presence] in Urine

1.46

0.47

2.3

2.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.43

0.46

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.43

0.45

1.1

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1069

10559

1.08

0.44

4.4

4.0

mmol/l

1.4

1.5

4.96

997

9916

(21494890) Protein electrophoresis panel - 24 hour Urine

1.45

0.44

1.0

2.5

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

193

1.25

0.43

3.3

3.7

e9/l

3.9

4.2

0.31

193

(4094501)

276

1.20

0.42

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

2.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

0.00

0.41

0.0

1.1

—

50.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.47

0.40

1.2

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.41

0.39

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

106

1.32

0.39

1.4

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

805

7896

1.05

0.39

3.6

3.3

—

(40768441) Liver Pathology biopsy report

1.37

0.38

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

197

1.22

0.38

1.1

u/ml

3.5

4.9

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

161

1.25

0.37

1.0

1.1

u/ml

0.1

0.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

180

1.23

0.36

1.1

u/ml

8.3

5.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

1009

10203

0.94

0.33

19.3

11.9

39.8

40.1

0.48

736

7982

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

173

1.22

0.33

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.32

0.31

1.1

1.5

—

(4211845)

1.27

0.30

2.3

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.25

0.29

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

122

1.23

0.27

1.1

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

141

1.21

0.26

1.1

—

(40768793) Breast Pathology biopsy report

318

0.88

0.24

1.2

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

212

0.85

0.24

2.3

4.0

u/ml

14.3

31.1

1.88

207

(4281824)

124

1.21

0.24

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

199

1.16

0.23

2.5

2.4

ug/min

27.3

132.9

1.98

125

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.28

0.23

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

1.20

0.22

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

231

0.86

0.22

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

231

0.86

0.22

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

2.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.16

0.21

2.0

3.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

134

1403

0.95

0.21

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.20

0.0

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.00

0.20

0.0

2.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.20

0.0

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3012441) Differential panel - Pleural fluid

1.20

0.19

1.0

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.15

0.19

1.0

1.3

mmol/l

6.3

6.8

—

(3045142) Bone marrow Pathology biopsy report

1.21

0.17

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

253

1.11

0.17

2.8

3.3

mg/l

1.2

1.4

1.51

234

(3025130) Human papilloma virus identified in Specimen

206

1.12

0.16

2.0

1.8

—

(40768800) Prostate Pathology biopsy report

0.79

0.14

1.4

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

198

1.11

0.14

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.17

0.13

1.5

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.16

0.11

1.7

3.0

nmol/l

0.8

0.17

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

524

1.05

0.11

1.6

mg/l

4.4

4.1

0.09

347

(40765089) Chromosome analysis panel - Blood by G-banded

1.14

0.10

1.0

—

(3000012) Reticulocyte production index

1.11

0.09

1.2

1.8

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.77

0.08

1.6

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.08

0.08

1.7

1.8

—

(21494434) Karyotype in Bone marrow

0.83

0.07

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.07

0.07

1.4

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.05

0.07

2.1

2.5

—

(3008037) Lactate [Moles/volume] in Venous blood

158

1.08

0.06

4.9

2.7

mmol/l

1.5

1.4

0.13

151

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1015

10175

0.99

0.05

4.0

3.6

mmol/l

1.5

1.3

5.67

942

9530

(40761536) Microorganisms panel - Urine sediment

904

0.98

0.03

5.8

3.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

100

1014

0.99

0.03

2.2

2.6

ug/l

0.5

0.7

4.47

583

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

452

1.02

0.01

2.0

1.8

—

(3000492) Spirometry study

110

1107

0.99

0.00

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

146

0.96

0.00

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

196

0.97

0.00

4.7

3.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

334

1.02

0.00

1.7

1.5

pmol/l

103.8

178.9

0.76

328

(1002224) Polysomnography panel

549

1.00

0.00

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

133

1333

1.00

0.00

1.7

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

243

2425

1.00

0.00

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.99

0.00

1.1

1.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

0.91

0.00

1.2

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.8

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.99

0.00

1.3

1.2

—

66.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

5.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.0

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.91

0.00

7.7

7.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

10.4

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

8.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ALGONEURO and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ALGONEURO	1.12 [0.97, 1.29]	0.115
Birth year	0.992 [0.98, 1.0]	0.07

During the follow-up period (1.1.1998 — 31.12.2019), 340 out of 4998 females with M13_ALGONEURO died.

Males

Parameter	HR [95% CI]	p-value
M13_ALGONEURO	1.281 [1.09, 1.5]	0.002
Birth year	0.988 [0.98, 1.0]	0.013

During the follow-up period (1.1.1998 — 31.12.2019), 253 out of 2184 males with M13_ALGONEURO died.

Mortality risk

Mortality risk for people of age

years, who have M13_ALGONEURO.

N-year risk	Females	Males
1	0.097%	0.313%
5	0.559%	1.621%
10	1.49%	3.979%
15	2.957%	7.149%
20	5.213%	11.809%

Relationships between endpoints

↥

Index endpoint: M13_ALGONEURO – Algoneurodystrophy

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Algoneurodystrophy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints